AU753658B2 - Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase - Google Patents

Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase Download PDF

Info

Publication number
AU753658B2
AU753658B2 AU80580/98A AU8058098A AU753658B2 AU 753658 B2 AU753658 B2 AU 753658B2 AU 80580/98 A AU80580/98 A AU 80580/98A AU 8058098 A AU8058098 A AU 8058098A AU 753658 B2 AU753658 B2 AU 753658B2
Authority
AU
Australia
Prior art keywords
compound
substituted
cells
alkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU80580/98A
Other languages
English (en)
Other versions
AU8058098A (en
Inventor
John J. Baldwin
Alan B. Cooper
Ronald J. Doll
Ashit Ganguly
Viyyoor M. Girijavallabhan
Chia-Yu Huang
John C Reader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Pharmacopeia LLC
Original Assignee
Pharmacopeia Inc
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacopeia Inc, Schering Corp filed Critical Pharmacopeia Inc
Publication of AU8058098A publication Critical patent/AU8058098A/en
Application granted granted Critical
Publication of AU753658B2 publication Critical patent/AU753658B2/en
Assigned to PHARMACOPEIA DRUG DISCOVERY, INC., SCHERING CORPORATION reassignment PHARMACOPEIA DRUG DISCOVERY, INC. Alteration of Name(s) in Register under S187 Assignors: PHARMACOPEIA, INC., SCHERING CORPORATION
Assigned to SCHERING CORPORATION, PHARMACOPEIA, INC. reassignment SCHERING CORPORATION Request to Amend Deed and Register Assignors: PHARMACOPEIA DRUG DISCOVERY, INC., SCHERING CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU80580/98A 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase Ceased AU753658B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87774197A 1997-06-17 1997-06-17
US08/877741 1997-06-17
PCT/US1998/011495 WO1998057960A1 (en) 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase

Publications (2)

Publication Number Publication Date
AU8058098A AU8058098A (en) 1999-01-04
AU753658B2 true AU753658B2 (en) 2002-10-24

Family

ID=25370618

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80580/98A Ceased AU753658B2 (en) 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase

Country Status (18)

Country Link
EP (1) EP0989983B1 (https=)
JP (1) JP2002504144A (https=)
KR (1) KR100640672B1 (https=)
CN (1) CN1266433A (https=)
AR (1) AR012991A1 (https=)
AT (1) ATE273299T1 (https=)
AU (1) AU753658B2 (https=)
CA (1) CA2293714C (https=)
DE (1) DE69825589T2 (https=)
ES (1) ES2224408T3 (https=)
HU (1) HUP0003138A3 (https=)
IL (2) IL133386A0 (https=)
MY (1) MY143570A (https=)
NZ (1) NZ501376A (https=)
PE (1) PE104798A1 (https=)
TW (1) TW587935B (https=)
WO (1) WO1998057960A1 (https=)
ZA (1) ZA985203B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
HUP0202152A2 (en) * 1998-12-18 2002-10-28 Schering Corp Tricyclyc farnesyl protein transferase inhibitors
US6800636B2 (en) 1998-12-18 2004-10-05 Schering Corporation Farnesyl protein transferase inhibitors
TR200101754T2 (tr) * 1998-12-18 2002-05-21 Schering Corporation Farnezil protein transferaz inhibitörleri
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
US6432959B1 (en) * 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
WO2002056884A2 (en) * 2001-01-22 2002-07-25 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002080895A2 (en) * 2001-04-06 2002-10-17 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
EP1542993B1 (en) 2002-09-20 2012-12-19 Merck Serono SA Piperazine derivatives and methods of use
EP1838324A2 (en) 2004-12-13 2007-10-03 Schering Corporation Novel farnesyl protein transferase inhibitors and their use to treat cancer
EP1833481A1 (en) 2004-12-14 2007-09-19 Schering Corporation Farnesyl protein transferase inhibitors and methods for treating proliferative diseases
ES2798289T3 (es) * 2012-01-25 2020-12-10 Novartis Ag Compuestos heterocíclicos y métodos para su uso
EP3541375B1 (en) * 2016-11-18 2023-08-23 Merck Sharp & Dohme LLC Factor xiia inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
CA2174105C (en) * 1993-10-15 2002-02-12 W. Robert Bishop Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
ES2224408T3 (es) 2005-03-01
CA2293714C (en) 2009-09-08
HUP0003138A3 (en) 2002-11-28
AR012991A1 (es) 2000-11-22
MY143570A (en) 2011-05-31
HUP0003138A2 (hu) 2001-06-28
KR100640672B1 (ko) 2006-11-02
DE69825589T2 (de) 2005-09-08
EP0989983A1 (en) 2000-04-05
EP0989983B1 (en) 2004-08-11
NZ501376A (en) 2002-03-28
CA2293714A1 (en) 1998-12-23
ATE273299T1 (de) 2004-08-15
DE69825589D1 (de) 2004-09-16
JP2002504144A (ja) 2002-02-05
CN1266433A (zh) 2000-09-13
PE104798A1 (es) 1999-11-06
KR20010013822A (ko) 2001-02-26
TW587935B (en) 2004-05-21
ZA985203B (en) 1999-01-05
AU8058098A (en) 1999-01-04
IL133386A0 (en) 2001-04-30
WO1998057960A1 (en) 1998-12-23
IL133386A (en) 2006-12-10

Similar Documents

Publication Publication Date Title
AU711238B2 (en) Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6372747B1 (en) Farnesyl protein transferase inhibitors
JP2999556B2 (ja) ファルネシルタンパク質トランスフェラーゼの阻害に有用な三環式化合物
US6228856B1 (en) Compounds useful for inhibition of farnesyl protein transferase
US6239140B1 (en) Compounds useful for inhibition of farnesyl protein transferase
AU753658B2 (en) Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
WO1998011097A1 (en) Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
AU776558B2 (en) Tricyclic farnesyl protein transferase inhibitors
CA2293712C (en) Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
US6689789B2 (en) Compounds useful for inhibition of farnesyl protein transferase
EP0942906B1 (en) Compounds useful for inhibition of farnesyl protein transferase
CA2294351C (en) Compounds useful for inhibition of farnesyl protein transferase
EP0993454B1 (en) Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
MXPA99012059A (en) Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
CZ84499A3 (cs) Substituované deriváty benzocykloheptapyridinu použitelné pro inhibici farnesylprotein transferasy
MXPA01006241A (en) Tricyclic farnesyl protein transferase inhibitors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)